Striatal Dopamine and Homovanillic Acid in Huntington's Disease
Overview
Authors
Affiliations
Using tissue taken post mortem from patients with neuropathologically confirmed Huntington's disease and a series of appropriate control cases, GABA, dopamine and homovanillic acid were measured in the caudate nucleus and the putamen. The previously reported loss of GABA in Huntington's disease was confirmed, while no change in dopamine concentrations and a loss of homovanillic acid in these striatal regions were observed. This loss could not be explained on the basis of agonal state or previous drug treatment.
Distinct Roles of Honeybee Gut Bacteria on Host Metabolism and Neurological Processes.
Zhang Z, Mu X, Shi Y, Zheng H Microbiol Spectr. 2022; 10(2):e0243821.
PMID: 35266810 PMC: 9045319. DOI: 10.1128/spectrum.02438-21.
Christodoulou C, Zachariou M, Tomazou M, Karatzas E, Demetriou C, Zamba-Papanicolaou E Int J Mol Sci. 2020; 21(19).
PMID: 33049985 PMC: 7582902. DOI: 10.3390/ijms21197414.
Huntington's disease: the coming of age.
Pandey M, Rajamma U J Genet. 2018; 97(3):649-664.
PMID: 30027901
Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System.
Takeuchi H, Kawashima R Curr Neuropharmacol. 2017; 16(4):460-474.
PMID: 29119929 PMC: 6018195. DOI: 10.2174/1570159X15666171109124839.
Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.
Morigaki R, Goto S Brain Sci. 2017; 7(6).
PMID: 28590448 PMC: 5483636. DOI: 10.3390/brainsci7060063.